Insmed (INSM)
NASDAQ: INSM
· Real-Time Price · USD
73.77
0.69 (0.94%)
At close: Jun 04, 2025, 3:59 PM
74.44
0.91%
After-hours: Jun 04, 2025, 07:59 PM EDT
Insmed Revenue Breakdown
| Period Ending | Dec 31, 2024 |
|---|---|
| Reportable Segment Revenue | 363.71M |
| Reportable Segment Revenue Growth | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|---|
| Europe And The Rest Of The World Revenue | 21.21M | 15.28M | 2.86M | 12.95M |
| Europe And The Rest Of The World Revenue Growth | +38.80% | +434.64% | -77.92% | n/a |
| Japan Revenue | 87.7M | 65.73M | 56.51M | 16.01M |
| Japan Revenue Growth | +33.42% | +16.33% | +253.03% | n/a |
| United States Revenue | 254.8M | 224.19M | 185.99M | 159.51M |
| United States Revenue Growth | +13.65% | +20.54% | +16.60% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 147.54M | 142.51M | 118.93M | 106.57M | 93.1M | 89.53M | 90.63M | 84.43M | 79.91M | 73.48M | 80.82M | 47.35M | 56.75M | 65.27M | 60.28M | 57.18M | 51.55M | 56.02M | 46.59M | 49.66M | 51.35M | 50.21M | 53.35M | 52.43M | 54.81M | 53.96M | 17.29M | 13.46M | 13.52M | 31.4M | 9.36M | 9.36M | 8.65M | 12.18M | 9.1M | 8.67M | 12.52M | 12.94M | 7.51M | 7.57M | 7.77M |
| Selling, General, and Administrative Revenue Growth | +3.53% | +19.83% | +11.60% | +14.46% | +3.99% | -1.21% | +7.34% | +5.65% | +8.76% | -9.08% | +70.68% | -16.56% | -13.05% | +8.27% | +5.43% | +10.92% | -7.98% | +20.25% | -6.20% | -3.28% | +2.27% | -5.89% | +1.74% | -4.34% | +1.58% | +212.09% | +28.50% | -0.47% | -56.95% | +235.69% | 0.00% | +8.10% | -28.95% | +33.90% | +4.96% | -30.77% | -3.28% | +72.40% | -0.77% | -2.58% | n/a |
| Research and Development Revenue | 152.58M | 179.73M | 150.81M | 146.75M | 121.08M | 137.03M | 109.15M | 196.97M | 127.86M | 124.76M | 99.87M | 88.53M | 84.36M | 76.35M | 70.35M | 64.66M | 61.39M | 67.81M | 41.41M | 35.75M | 36.18M | 32.63M | 34.34M | 33.54M | 31.2M | 39.92M | 39.54M | 35.72M | 30.1M | 33.95M | 26.68M | 26.87M | 22.25M | 54.87M | 23.43M | 23.87M | 20.55M | 19.65M | 19.22M | 18.25M | 17.16M |
| Research and Development Revenue Growth | -15.11% | +19.18% | +2.77% | +21.20% | -11.64% | +25.54% | -44.59% | +54.04% | +2.49% | +24.92% | +12.82% | +4.94% | +10.48% | +8.54% | +8.80% | +5.32% | -9.47% | +63.76% | +15.84% | -1.20% | +10.89% | -4.98% | +2.39% | +7.48% | -21.85% | +0.98% | +10.68% | +18.69% | -11.34% | +27.27% | -0.73% | +20.75% | -59.44% | +134.16% | -1.83% | +16.18% | +4.59% | +2.21% | +5.34% | +6.30% | n/a |